Víctor Macías

ORCID: 0000-0003-2904-5715
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Advanced Radiotherapy Techniques
  • Bladder and Urothelial Cancer Treatments
  • Radiation Therapy and Dosimetry
  • Family Business Performance and Succession
  • Head and Neck Cancer Studies
  • Education and Teacher Training
  • Lung Cancer Diagnosis and Treatment
  • Educational Research and Science Teaching
  • Advances in Oncology and Radiotherapy
  • Business, Innovation, and Economy
  • Bone Tumor Diagnosis and Treatments
  • Medical Imaging and Pathology Studies
  • Patient-Provider Communication in Healthcare
  • Management of metastatic bone disease
  • Radiation Dose and Imaging
  • Higher Education Teaching and Evaluation
  • Global Cancer Incidence and Screening
  • Patient Satisfaction in Healthcare
  • Radiopharmaceutical Chemistry and Applications
  • Health Systems, Economic Evaluations, Quality of Life
  • Higher Education and Sustainability
  • Educational and Organizational Development
  • E-Learning and Knowledge Management

Hospital Universitari i Politècnic La Fe
2019-2022

Hospital General de Catalunya
2003-2021

Universidad de Manizales
2017-2021

Hospital Del Mar
2021

Hospital del Mar Research Institute
2021

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2021

Universitat Autònoma de Barcelona
2021

Complejo Hospitalario de Salamanca
2009-2019

Universidad de Salamanca
2013-2016

Hospital Clínico Universitario de Valencia
2013

Earlier studies evaluating the effect on quality of life (QoL) localized prostate cancer interventions included patients receiving adjuvant hormone therapy, which could have affected their outcomes. Our objective was to compare QoL impact three most common primary treatments who were not hormonal treatment.This a prospective study 435 treated with radical prostatectomy, external-beam radiotherapy, or brachytherapy. assessed before and after treatment Short Form-36 Expanded Prostate Cancer...

10.1200/jco.2009.25.3245 article EN Journal of Clinical Oncology 2010-10-05

Purpose: To describe decisional roles of patients with early-stage prostate cancer in 9 countries and to compare the information they rated important for decision making (DM). Method: A survey recently treated was conducted Canada, Italy, England, Germany, Poland, Portugal, Netherlands, Spain, Turkey. Participants indicated their role actual would prefer now. Each participant also (essential/desired/no opinion/avoid) importance obtaining answers, between diagnosis treatment decision, each 92...

10.1177/0272989x10395029 article EN Medical Decision Making 2011-01-27

Endpoint: To assess early urinary (GU) and rectal (GI) toxicities after helical tomotherapy Stereotactic body radiation therapy (SBRT), to determine their predictive factors.Since May 2012, 45 prostate cancer patients were treated with eight fractions of 5.48 (low risk, 29%) or 5.65 Gy (intermediate-high 71%) on alternative days over 2.5 weeks. The exclusion criteria Gleason score 9-10, PSA >40 ng/mL, cT3b-4, IPSS ≥20, history acute retention. During the follow-up, a set potential prognostic...

10.3389/fonc.2014.00336 article EN cc-by Frontiers in Oncology 2014-11-26

Abstract To compare the effectiveness at ten years of follow-up radical prostatectomy, brachytherapy and external radiotherapy, in terms overall survival, prostate cancer-specific mortality biochemical recurrence. Cohort men diagnosed with localized cancer (T1/T2 low/intermediate risk) from Spanish hospitals, followed for 10 years. The treatment selection was decided jointly by patients physicians. Of 704 participants, 192 were treated open retropubic 317 125 I alone, 195 3D beam radiation....

10.1038/s41598-022-16395-w article EN cc-by Scientific Reports 2022-07-22

Long-term comparative effectiveness research on localized prostate cancer treatments is scarce, and evidence lacking especially for brachytherapy. The aim of this study was to assess the long-term impact side effects radical prostatectomy, brachytherapy, external radiation therapy patients with at 10 years, using propensity score analyses.

10.1016/j.ijrobp.2020.12.032 article EN cc-by-nc-nd International Journal of Radiation Oncology*Biology*Physics 2021-01-01

Aims and Background Postoperative radiation is often given in cases of cervical chordoma because the high incidence local recurrence. The tumor mass usually surrounds spinal cord infiltrates vertebral bone. A combined technique using protons or electrons to boost initial photon fields generally applied. We evaluated use dynamic intensity-modulated therapy as an alternative for treating advanced chordoma. Methods Study Design female patient with incomplete resection a surrounding C2-C3 was...

10.1177/030089160308900313 article EN Tumori Journal 2003-05-01

Este artículo es resultado de la investigación titulada “La sucesión en las empresas familia: un análisis desde teoría agencia”, el que se exponen los principales enfoques agencia y su aplicación al caso familia; además presentan hallazgos relacionados con prácticas para dirección vinculación nuevos familiares, estudio siete casos del departamento Caldas, Colombia. Para desarrollo hace recorrido por construcción teórica diversos autores han realizado sobre conceptos como familia, proceso...

10.18041/1900-0642/criteriolibre.2011v9n15.1208 article ES cc-by-nc-nd Criterio Libre 2017-12-05

4580 Background: Hormone therapy plus radiotherapy significantly decreases recurrences and mortality of patients affected by locally advanced prostate cancer (PCa). Controversy remains about the optimal duration androgen deprivation (AD) when associated to high-dose (HDRT). This trial was designed determine whether long-term AD (LTAD) is superior short-term (STAD) in setting HDRT Methods: Eligibility included with cT1c-T3aN0M0 adenocarcinoma intermediate high risk factors according NCCN...

10.1200/jco.2011.29.15_suppl.4580 article EN Journal of Clinical Oncology 2011-05-20
Coming Soon ...